ArticleACS medicinal chemistry letters2016

Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.

Heng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.